Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06841536Not ApplicableCompleted

Combined Effects of Statins and Exercise on Training Sensitive Health Markers

Role: lead

NCT06478173Not ApplicableCompleted

Exercise Training and Type 2 Diabetes

Role: lead

NCT06578494Not ApplicableNot Yet Recruiting

The Efficacy of Implementing Nurse-performed Ultrasound-guided Peripheral Intravenous Access in Oncology Patients

Role: collaborator

NCT05234294Unknown

Long Covid After COVID-19 Infection With Omicron Variant

Role: collaborator

NCT03011203Not ApplicableCompleted

Acute Nutritional Ketosis in GSD IIIa

Role: collaborator

All 5 trials loaded